MW3782A1 - Human proinsulin pharmaceutical formulations - Google Patents

Human proinsulin pharmaceutical formulations

Info

Publication number
MW3782A1
MW3782A1 MW37/82A MW3782A MW3782A1 MW 3782 A1 MW3782 A1 MW 3782A1 MW 37/82 A MW37/82 A MW 37/82A MW 3782 A MW3782 A MW 3782A MW 3782 A1 MW3782 A1 MW 3782A1
Authority
MW
MALAWI
Prior art keywords
pharmaceutical formulations
human proinsulin
proinsulin
human
formulations
Prior art date
Application number
MW37/82A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MW3782A1 publication Critical patent/MW3782A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MW37/82A 1981-08-27 1982-08-24 Human proinsulin pharmaceutical formulations MW3782A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29675281A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
MW3782A1 true MW3782A1 (en) 1984-06-13

Family

ID=23143402

Family Applications (1)

Application Number Title Priority Date Filing Date
MW37/82A MW3782A1 (en) 1981-08-27 1982-08-24 Human proinsulin pharmaceutical formulations

Country Status (21)

Country Link
JP (1) JPS5846023A (xx)
AU (1) AU552054B2 (xx)
BE (1) BE894186A (xx)
CA (1) CA1176160A (xx)
CH (1) CH650677A5 (xx)
DE (1) DE3232036A1 (xx)
FR (1) FR2511866B1 (xx)
GB (1) GB2104380B (xx)
HU (1) HU193522B (xx)
IE (1) IE53829B1 (xx)
IL (1) IL66610A (xx)
IT (1) IT1153184B (xx)
LU (1) LU84358A1 (xx)
MW (1) MW3782A1 (xx)
MY (1) MY8700757A (xx)
NL (1) NL8203316A (xx)
NZ (1) NZ201683A (xx)
PH (1) PH18716A (xx)
SE (1) SE8204871L (xx)
ZA (1) ZA826157B (xx)
ZW (1) ZW17382A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
EP0166971B1 (de) * 1984-06-09 1990-02-28 Hoechst Aktiengesellschaft Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
ES2331342B1 (es) * 2006-05-22 2010-10-13 Consejo Superior Investg.Cientificas Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones.
USD1010056S1 (en) * 2020-08-25 2024-01-02 Magpul Industries Corp. Gun sight

Also Published As

Publication number Publication date
HU193522B (en) 1987-10-28
LU84358A1 (fr) 1983-02-28
ZW17382A1 (en) 1982-11-17
IL66610A0 (en) 1982-12-31
IE53829B1 (en) 1989-03-15
FR2511866A1 (fr) 1983-03-04
GB2104380B (en) 1984-12-05
PH18716A (xx) 1985-09-11
ZA826157B (en) 1984-04-25
NL8203316A (nl) 1983-03-16
IL66610A (en) 1985-11-29
FR2511866B1 (fr) 1986-08-14
AU8759582A (en) 1983-03-03
BE894186A (fr) 1983-02-24
IT1153184B (it) 1987-01-14
IT8223019A0 (it) 1982-08-27
JPS5846023A (ja) 1983-03-17
IE822062L (en) 1983-02-27
SE8204871D0 (sv) 1982-08-25
MY8700757A (en) 1987-12-31
CA1176160A (en) 1984-10-16
NZ201683A (en) 1985-08-16
CH650677A5 (de) 1985-08-15
AU552054B2 (en) 1986-05-22
SE8204871L (sv) 1983-02-28
DE3232036A1 (de) 1983-03-10
GB2104380A (en) 1983-03-09

Similar Documents

Publication Publication Date Title
ZA828797B (en) Pharmaceutical formulation
DE3378523D1 (en) Pharmaceutical formulations
DE3264782D1 (en) Medicinal formulation
KE3814A (en) Pharmaceutical formulations
GB2105191B (en) Pharmaceutical formulations comprising human insulin and human proinsulin
MW3882A1 (en) Pharmaceutical formulations comprising human insulin human c-peptide
GB2104380B (en) Human proinsulin pharmaceutical formulations
DE3466477D1 (en) Pharmaceutical formulations
ZA822120B (en) Pharmaceutical preparation
ZA833692B (en) Pharmaceutical formulations
IE812104L (en) Novel insulin formulations based on human insulin
IE810190L (en) Pharmaceutical preparation containing¹poly-glycidyl-substituted n-heterocyclics
GB8313036D0 (en) Pharmaceutical formulations
GB8316497D0 (en) Pharmaceutical formulations
GB8300648D0 (en) Pharmaceutical formulations
GB8316495D0 (en) Pharmaceutical formulations
GB8316498D0 (en) Pharmaceutical formulations
GB8332451D0 (en) Pharmaceutical formulations
GB8319759D0 (en) Pharmaceutical formulations
GB8319760D0 (en) Pharmaceutical formulations
GB8316496D0 (en) Pharmaceutical formulations
IE811106L (en) Controlled release oral pharmaceutical preparations